¢ºÀüÀÏ ¹Ì±¹ ÁÖ¿ä À妽º
* ´Ù¿ì +0.5% S&P Á¦¾à +0.1% ³ª½º´Ú ¹ÙÀÌ¿À +1.1%
¢ºÇØ¿Ü Peer ÀüÀÏ ÁÖ°¡
* ¼¿Æ®¸®¿Â °ü·Ã: Pfizer +1.4% J&J -0.3% Teva +0.2% Mylan +0.3%
* »ï¼º¹ÙÀÌ¿À °ü·Ã: Lonza +0.2% Merck +0.1% Roche -1.1% Amgen +1.9% Biogen +2.6%
* Çѹ̾àÇ° °ü·Ã: Sanofi +1.5% Spectrum -2.9%
* º¸Å彺: Allergan +1% Revance Therapeutic -0.8% Evolus -0.1%
* ±âŸ: Gilead Science +1.3% Regeneron +1.7% Abbvie +1.7% Celgene +0.2% Eli Lilly +0.7% CSL -0.1%
¢º±¹³» À̽´
* ½ºÆåÆ®·³ "ÇÑ¹Ì '·Ñ·ÐƼ½º' BLA ÀÚÁøÃëÇÏ..Àç½Åû"
http://bit.ly/2uaOx6h
* ¸ÞµðÆ÷½ºÆ® "Àüȯ»çä 400¾ï, Àӻ󡤻ý»ê¶óÀÎ Áõ¼³ ÅõÀÔ"
http://bit.ly/2uePRoC
* µ¿¾ÆST ¸®º£ÀÌÆ® 87°³ Ç°¸ñ '±Þ¿©Á¤Áö 2°³¿ù' È®Á¤
http://bit.ly/2FbZV6X
* Â÷¹ÙÀÌ¿ÀÅØ, ±â¼úÆò°¡ AA µî±Þ ȹµæ
http://bit.ly/2TYdVum
* À¯¹æ¾Ï Ä¡·áÁ¦ 'ÆĽ½·Îµ¦½º' ´Üµ¶¿ä¹ý, 11³â¸¸¿¡ ±Þ¿©
http://bit.ly/2TEWOOW
* STRI,°£¼¼Æ÷ ºÐÈ Æ¯Çã ±¹³» µî·Ï...Áß°£¿± Áٱ⼼Æ÷ ÃÖÃÊ
http://bit.ly/2FbAgvi
* ¿ÜºÎ °¨»ç ¹ÞÀº Á¦¾à¹ÙÀÌ¿À»ç, 'ÀûÀÚ È®´ë' ¼ÓÃâ
http://bit.ly/2JiHYZD
* Á¦³×¸¯ ¾à°¡, 3°³ ¿ä°Ç µû¶ó Â÷µîÀÎÇÏ¡¦À̹øÁÖ Áß ¹ßÇ¥
http://bit.ly/2JlFGZO
¢ºÇØ¿Ü À̽´
* ·Î½´ ¡®¸¿Å×¶ó¡¯ ½É»ó¼º õÆ÷â ÀûÀÀÁõ EU ½ÂÀÎ
http://bit.ly/2ubMUFg
* ½Å±Ô ºóÇ÷Ä¡·á¾à ¡®¹Ù´ÙµÎ½ºÅ¸Æ®¡¯ ìí½ÂÀνÅû ÀÓ¹Ú
http://bit.ly/2uaeoLA
* ACC: BMS, Pfizer's Eliquis tops warfarin in high-risk Afib subgroup
http://bit.ly/2Y0y9TL |